WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals
World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , 

ISSN 2457-0400

Impact Factor  :  6.711

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • WJAHR: FEBRUARY ISSUE PUBLISHED

    FEBRUARY 2024 Issue has been successfully launched on 1 FEBRUARY 2024.

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased to 6.711 for Year 2024.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR February 2023 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

ASSESSMENT OF SERUM IRISIN HORMONE LEVEL IN NEWLY DIAGNOSED HYPOTHYROIDISM PATIENTS

*Maysam Hamzah Abdulwahid and Prof. Dr. Manal Kamal Rasheed

ABSTRACT

Introduction: Thyroid hormones control obligatory and facultative thermogenesis and affect cardiovascular health. Due to altered lipid metabolism and musculoskeletal system abnormalities, thyroid dysfunction increases cardiovascular risk. This study was designed to determine the relationship between irisin hormone and lipid profile parameter and body mass index in hypothyroidism patients. Method: Eighty-eight participants were studied. Forty-four were newly diagnosed with hypothyroidism over 18 years old, while forty-four were healthy volunteers (matching in age and sex). Electro-chemiluminescence immunoassay assessed blood TSH, FT4, Antithyroglobulin, and antithyroid peroxidase. ELISA measured serum irisin. Blood pressure, BMI, and homogeneous enzymatic colorimetric lipid profile were assessed. Results: The results showed significant differences between patients and control groups by increase in systolic blood pressure, diastolic blood pressure, total cholesterol, triglyceride, low density lipoprotein, thyroid stimulating hormone, anti-thyroid peroxidase, and anti-thyroglobulin with p-value (0.00, 0.00, 0.002, 0.04, 0.03, 0.00, 0.00, 0.00) respectively, and significant difference by decrease in high density lipoprotein, free thyroglobulin, and Hypothyroidism patients had lower irisin levels than controls (p=0.000). Irisin is adversely linked with total cholesterol, triglycerides, and body mass index in obese hypothyroid patients (p-value 0.02). Irisin correlated positively with Anti-TPO and negatively with Anti-TG. Irisin was positively correlated with total cholesterol and Anti-TG in control group with p-value 0.04. Conclusion: Circulating irisin and a good lipid profile may lower the risk of non-communicable diseases. In hypothyroidism patients, irisin linked adversely with BMI (irisin hormone similar to thyroid hormone action). Chronic inflammation releases fibronectin type III domain-containing 5 genes, which increases irisin and anti-thyroid peroxidase in hypothyroidism patients.

[Full Text Article] [Download Certificate]